Opportunity Information: Apply for CDC RFA GH15 16300301SUPP17
This CDC cooperative agreement opportunity (CDC RFA GH15 16300301SUPP17) focuses on helping Liberia sustain and strengthen the core health system functions that were severely strained during the Ebola virus disease (EVD) crisis, especially as hospitals and clinics reopen and return to routine service delivery. Liberia was one of the three West African countries hit hardest by Ebola, and the grant is framed around a practical reality from the outbreak: early Ebola symptoms often look like many common conditions seen every day in clinical settings, such as malaria, other viral illnesses, or complications of pregnancy. That overlap makes it easy to miss Ebola cases early and also increases the risk of exposure for health care workers if triage and infection control are not consistently applied.
A central aim of the award is to reduce infection risk among health care workers, who were among the most impacted groups during the outbreak (more than 360 cases and about 170 deaths among health care workers in Liberia, as cited in the opportunity). The project would implement comprehensive Infection Prevention and Control (IPC) training and then go beyond one-time instruction by providing ongoing support and monitoring for frontline staff, particularly in Eastern Liberia. The intent is to make safe triage and patient management routine and durable, so that facilities can identify suspected EVD cases quickly while protecting staff and other patients from potential exposure.
A second major component is strengthening clinical laboratory capacity so facilities can get faster, more reliable answers for Ebola and for other illnesses that present with similar symptoms. The grant emphasizes the value of having rapid diagnostics available closer to the point of care, including the potential role of direct PCR testing or other rapid diagnostic approaches within hospital laboratories. Faster testing supports better clinical decisions: it helps ensure Ebola patients are isolated and treated appropriately, while non-Ebola patients are not unnecessarily diverted or delayed from receiving care. Alongside in-hospital testing capacity, the opportunity also highlights improving specimen referral systems, including transportation processes from hospital labs to reference laboratories, so that testing access is reliable even where advanced diagnostics are not available on site.
The laboratory strengthening approach also includes a system-design element: geographically aligning laboratories to maximize coverage across the country, reduce gaps in access, and improve how samples move through the network. This alignment is meant to increase overall testing reach and efficiency while also creating clearer pathways for education, mentorship, and skills development for Liberian laboratory technicians. In other words, the award is not just about equipment or test kits, but about building a coordinated laboratory network with trained personnel, workable logistics, and sustainable practices.
A third key pillar is improving blood transfusion services in Liberia, presented as a rare opportunity to build lasting capacity while responding to an urgent clinical need. During the outbreak, convalescent plasma and whole blood from Ebola survivors were used based on the theory that survivor antibodies could provide some level of immunity or partial protection to acutely ill patients. Although controlled trials had not definitively proven effectiveness at the time, convalescent plasma had become a commonly used treatment approach in the United States during the epidemic. In Liberia, the opportunity notes that the Bill and Melinda Gates Foundation was funding a clinical trial at ELWA to evaluate convalescent plasma. This CDC award would support strengthening donor collection and implementing component therapy systems so that convalescent plasma can be collected, processed, and stored. The practical promise is scale and readiness: better transfusion services could support larger-volume therapeutic use and potentially prophylactic use during outbreaks, and stored plasma could improve preparedness for future Ebola flare-ups in Liberia and potentially other affected West African countries.
From an administrative standpoint, the opportunity is a discretionary funding announcement from the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health, offered as a cooperative agreement (meaning CDC would likely have substantial involvement in program direction and oversight compared with a standard grant). The CFDA number listed is 93.318. The announcement anticipated a single award, with an award ceiling of up to $10,000,000. The posting indicates it was created March 31, 2017, with an original closing date of April 27, 2017, and electronic applications due by 5:00 p.m. Eastern Time on the deadline. Eligibility is listed broadly as "Others" with clarification referenced in an additional eligibility section. Overall, the opportunity is designed to build lasting, integrated capacity across infection control, diagnostic laboratory systems, specimen transport networks, workforce training, and transfusion services, so Liberia can better manage Ebola risk while strengthening everyday health service delivery.Apply for CDC RFA GH15 16300301SUPP17
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "COPY OF Sustained Strengthening of Public Health Laboratory, Transfusion Services, and Health Care Worker Infection Control Practices for Ebola Virus Disease in Liberia" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.318.
- This funding opportunity was created on Mar 31, 2017.
- Applicants must submit their applications by Apr 27, 2017 Electronically submitted applications must be submitted no later than 500 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $10,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the purpose of CDC RFA GH15 16300301SUPP17?
This CDC cooperative agreement opportunity focuses on helping Liberia sustain and strengthen core health system functions that were severely strained during the Ebola virus disease (EVD) crisis, especially as hospitals and clinics reopen and return to routine service delivery.
Why does the opportunity emphasize triage and infection prevention and control (IPC)?
The opportunity is framed around a key reality from the Ebola outbreak: early Ebola symptoms can resemble common conditions frequently seen in clinical care (such as malaria, other viral illnesses, or complications of pregnancy). Because of that overlap, Ebola can be missed early, and health care workers may be exposed if triage and infection control are not applied consistently.
Who is a central focus of the project and why?
Health care workers are a central focus because they were among the most impacted groups during the outbreak in Liberia. The opportunity cites more than 360 cases and about 170 deaths among health care workers in Liberia, underscoring the need to reduce infection risk for frontline staff.
What geographic area is highlighted for frontline IPC support?
The opportunity particularly emphasizes providing ongoing support and monitoring for frontline staff in Eastern Liberia as part of making safe triage and patient management routine and durable.
Is the IPC approach limited to one-time training?
No. The project would implement comprehensive IPC training and then go beyond one-time instruction by providing ongoing support and monitoring to help ensure safe practices become routine and long-lasting in health facilities.
What is the intended outcome of strengthening IPC in health facilities?
The intent is to make safe triage and patient management routine and durable so that facilities can identify suspected EVD cases quickly while protecting staff and other patients from potential exposure.
Why is strengthening clinical laboratory capacity a major component of the award?
Strengthening laboratory capacity supports faster, more reliable answers for Ebola and for other illnesses that present with similar symptoms. Faster diagnostics help clinicians make better decisions, including isolating and treating Ebola patients appropriately while avoiding unnecessary diversion or delays in care for non-Ebola patients.
What types of diagnostic approaches are mentioned?
The opportunity emphasizes the value of having rapid diagnostics available closer to the point of care, including the potential role of direct PCR testing or other rapid diagnostic approaches within hospital laboratories.
How does faster testing affect patient management?
Faster testing helps ensure Ebola patients are identified and isolated quickly and treated appropriately. It also helps ensure that patients who do not have Ebola are not unnecessarily diverted or delayed from receiving routine care.
What is meant by improving specimen referral systems?
The opportunity highlights improving the processes that move specimens from hospital laboratories to reference laboratories, including transportation. The goal is reliable access to testing even when advanced diagnostics are not available on site.
Does the laboratory component include a national system design element?
Yes. The opportunity describes geographically aligning laboratories to maximize coverage across Liberia, reduce gaps in access, and improve how samples move through the network.
Beyond equipment and test kits, what does the laboratory strengthening approach aim to build?
It aims to build a coordinated laboratory network with trained personnel, workable logistics, and sustainable practices. It also seeks to create clearer pathways for education, mentorship, and skills development for Liberian laboratory technicians.
What is the third key pillar of the opportunity?
A third key pillar is improving blood transfusion services in Liberia, presented as an opportunity to build lasting capacity while responding to urgent clinical needs related to Ebola.
How does convalescent plasma relate to this opportunity?
During the outbreak, convalescent plasma and whole blood from Ebola survivors were used based on the theory that survivor antibodies might provide some immunity or partial protection to acutely ill patients. The opportunity notes that, although controlled trials had not definitively proven effectiveness at the time, convalescent plasma had become a commonly used treatment approach in the United States during the epidemic.
What related research activity in Liberia is mentioned?
The opportunity notes that the Bill and Melinda Gates Foundation was funding a clinical trial at ELWA to evaluate convalescent plasma.
What specific transfusion-related capacities would this CDC award support?
The award would support strengthening donor collection and implementing component therapy systems so that convalescent plasma can be collected, processed, and stored.
How is strengthening transfusion services linked to preparedness?
The opportunity suggests that improved transfusion services could support larger-volume therapeutic use and potentially prophylactic use during outbreaks, and that stored plasma could improve readiness for future Ebola flare-ups in Liberia and potentially other affected West African countries.
Which U.S. agency and program area are offering this funding?
This is a discretionary funding announcement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Center for Global Health.
What type of funding mechanism is used?
The opportunity is offered as a cooperative agreement, meaning CDC would likely have substantial involvement in program direction and oversight compared with a standard grant.
What is the CFDA number listed for this opportunity?
The CFDA number listed is 93.318.
How many awards were anticipated and what was the maximum funding level?
The announcement anticipated a single award, with an award ceiling of up to $10,000,000.
When was the opportunity posted and what were the application deadline details?
The posting indicates it was created on March 31, 2017. The original closing date was April 27, 2017, and electronic applications were due by 5:00 p.m. Eastern Time on the deadline.
Who was eligible to apply based on the information provided?
Eligibility is listed broadly as "Others," with a note that additional clarification is referenced in an additional eligibility section.
What overall capacities is the opportunity designed to strengthen?
Overall, the opportunity is designed to build lasting, integrated capacity across infection control, diagnostic laboratory systems, specimen transport networks, workforce training, and transfusion services so Liberia can better manage Ebola risk while strengthening everyday health service delivery.
Browse more opportunities from the same category: Health
Next opportunity: Monarch Butterfly Conservation Fund
Previous opportunity: Petrology and Geochemistry
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 16300301SUPP17
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 16300301SUPP17) also looked into and applied for these:
| Funding Opportunity |
|---|
| Resource Centers for Minority Aging (RCMAR) Coordinating Center (R24) Apply for RFA AG 18 004 Funding Number: RFA AG 18 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $200,000 |
| Data to Care Rx: Using Real-time Prescription Claims Data to Support the HIV Care Continuum Apply for CDC RFA PS17 1709 Funding Number: CDC RFA PS17 1709 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: $875,000 |
| DREAMS Initiative Namibia Apply for RFI 673 17 000001 Funding Number: RFI 673 17 000001 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $20,000,000 |
| Developing professional training programs to increase capacity for effective global health response to humanitarian emergencies Apply for CDC RFA GH15 162403CONT17 Funding Number: CDC RFA GH15 162403CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Integrative Computational Biology for Analysis of NHLBI TOPMed Data Apply for RFA HL 18 020 Funding Number: RFA HL 18 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $324,000 |
| Scaling the National Diabetes Prevention Program in Underserved Areas Apply for CDC RFA DP17 1705 Funding Number: CDC RFA DP17 1705 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $1,500,000 |
| National Organization to Strengthen and Support a Network of Immunization Program Managers Apply for CDC RFA IP17 1703 Funding Number: CDC RFA IP17 1703 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: $600,000 |
| Supplement: Support Services from the World Health Organization (WHO) for the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 13270401SUPP17 Funding Number: CDC RFA GH13 13270401SUPP17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $9,420,000 |
| Supplement: Strengthening Public Health Capacity and Strategic Information Systems through Cooperation and Support Services from the Joint United Nations Programme on HIV/AIDS (UNAIDS) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 16170201SUPP17 Funding Number: CDC RFA GH16 16170201SUPP17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $525,000 |
| Health Professional Support Program for Children with Congenital Zika Virus (ZIKV) Infection Apply for HRSA 17 116 Funding Number: HRSA 17 116 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $80,000 |
| Health Workforce for HIV and Chronic Disease Service Delivery Global Initiative Apply for HRSA 17 033 Funding Number: HRSA 17 033 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Optimizing Momentum Toward Sustainable Epidemic Control Apply for HRSA 17 103 Funding Number: HRSA 17 103 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Behavioral Health Workforce Education and Training (BHWET) Program Apply for HRSA 17 070 Funding Number: HRSA 17 070 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Organizations for State and Local Officials (NOSLO) Apply for HRSA 17 075 Funding Number: HRSA 17 075 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening South Africas Laboratory and Epidemiology Capacity to Detect and Respond to Zoonotic Disease Outbreaks, Center for Global Health Apply for CDC RFA GH15 162203CONT17 Funding Number: CDC RFA GH15 162203CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Assuring Comprehensive Prevention and Treatment for Families Affected by HIV to Eliminate Perinatal HIV Transmission in the United States Apply for CDC RFA PS17 1712 Funding Number: CDC RFA PS17 1712 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: $400,000 |
| ServingLife Apply for RFA 121 17 000002 Funding Number: RFA 121 17 000002 Agency: Agency for International Development, Ukraine USAID-Kiev Category: Health Funding Amount: $10,000,000 |
| NIH Director's Early Independence Awards (DP5) Apply for RFA RM 17 008 Funding Number: RFA RM 17 008 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $250,000 |
| CDC Undergraduate Public Health Scholars Program (CUPS): A Public Health Experience to Expose Undergraduate and Graduate Students to Minority Health, Public Health and Health Professions Apply for CDC RFA MN17 1701 Funding Number: CDC RFA MN17 1701 Agency: Department of Health and Human Services, Centers for Disease Control - OD Category: Health Funding Amount: $850,000 |
| Limited Competition: National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24) Apply for RFA MH 18 250 Funding Number: RFA MH 18 250 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $775,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 16300301SUPP17", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.